Skip to content

Effects of cerebellar vermis intermittent theta-burst stimulation on balance function in stroke patients

Effects of cerebellar vermis intermittent theta-burst stimulation on balance function in stroke patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048915
Enrollment
Unknown
Registered
2021-07-19
Start date
2021-07-19
Completion date
Unknown
Last updated
2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

control group:Conventional rehabilitation program for two weeks
experimental group:Conventional rehabilitation program and iTBS for two weeks

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for cerebral infarction or cerebral hemorrhage in ''Key Points for Diagnosis of Various Major Cerebrovascular Diseases in China 2019'' formulated by the Vascular Disease Group of the Neurology Branch of the Chinese Medical Association; 2. Unilateral stroke and the first onset must be confirmed by cranial computed tomography or magnetic resonance imaging; 3. Aged between 18 and 65 years; 4. The course of the disease is more than 2 weeks, and the condition is stable; 5. There is balance dysfunction, standing balance can reach grade I; 6. Agree to participate in the trial and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. History of other neurological diseases (including traumatic brain injury) or mental disorders other than stroke; 2. Cerebellum or brainstem injury; 3. Subjects with contraindications to TMS, such as wearing a pacemaker, intracranial metal implants or skull defects, previous history of epilepsy, pregnancy, etc.; 4. Severe cognitive or speech impairment; 5. Complicated with heart, lung, liver, kidney and other important organ dysfunction or other serious physical diseases; 6. Participate in other TMS-related studies during the same period.

Design outcomes

Primary

MeasureTime frame
Berg Balance Scale;

Secondary

MeasureTime frame
Dynamic Balancer Test Score (Maximum Offset);Mean Functional Near-infrared Blood Oxygen Concentration;Dynamic Balancer Test Score (Directional Control);Dynamic Balancer Test Score (Movement Speed);Dynamic Balancer Test Score (Reaction Time);

Countries

China

Contacts

Public ContactGao Qiang

Sichuan University

gaoqiang_hxkf@163.com+86 18980605992

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026